Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026)
Delcath Systems (DCTH) posted Cash from Investing Activities of -$504000.0 for Q2 2026, up 11.73% on a QoQ basis from -$571000.0 in Q1 2026, and down 21.45% year-over-year from -$641595.1 in Q2 2025.
Analysis
Delcath Systems (DCTH) Cash from Investing Activities (2010 - 2026) Analysis & Trends
Delcath Systems has reported Cash from Investing Activities for 17 years, with the latest figure at -$504000.0 in Q2 2026.
- On a quarterly basis, Cash from Investing Activities fell 21.45% year-over-year to -$504000.0 in Q2 2026; TTM through Jun 2026 was -$2.1 million, a 94.93% increase from a year earlier, with the FY2025 full-year figure at -$26.6 million, down 2610.5% from the prior year.
- Cash from Investing Activities was -$504000.0 for Q2 2026 at Delcath Systems, up from -$571000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $10.3 million in Q2 2024, with the low at -$25.1 million in Q1 2025.
- Average Cash from Investing Activities over 5 years is -$3.0 million, with a median of -$440500.0 recorded in 2025.
- The largest YoY upside for Cash from Investing Activities was 25810.0% in 2024 against a maximum downside of 69800.0% in 2024.
- Over 5 years, Cash from Investing Activities stood at -$68000.0 in 2022, then slumped by 28826.47% to -$19.7 million in 2023, then increased by 22.58% to -$15.2 million in 2024, then surged by 96.32% to -$561000.0 in 2025, then grew by 10.16% to -$504000.0 in 2026.
- The last three Cash from Investing Activities figures came in at -$504000.0 (Q2 2026), -$571000.0 (Q1 2026), and -$561000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | -673.00 Mn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | -1.62 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | -639.00 Mn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | -1.96 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | -193.20 Mn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | -222.00 Mn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | 329.80 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -108.50 Mn |
| 10 | Delcath Systems | 575.53 Mn | 479.61 Mn | 26.15 Mn | -504,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -504,000.00 |
| Mar 31, 2026 | -571,000.00 |
| Dec 31, 2025 | -561,000.00 |
| Sep 30, 2025 | -466,000.00 |
| Jun 30, 2025 | -415,000.00 |
| Mar 31, 2025 | -25.15 Mn |
| Dec 31, 2024 | -15.23 Mn |
| Sep 30, 2024 | -697,000.00 |
| Jun 30, 2024 | 10.28 Mn |
| Mar 31, 2024 | 4.66 Mn |
| Dec 31, 2023 | -19.67 Mn |
| Sep 30, 2023 | 1,000.00 |
| Jun 30, 2023 | -40,000.00 |
| Sep 30, 2022 | -68,000.00 |
| Jun 30, 2022 | -52,000.00 |
| Mar 31, 2022 | -89,000.00 |
| Dec 31, 2021 | 1,000.00 |
| Sep 30, 2021 | -56,000.00 |
| Jun 30, 2021 | -79,000.00 |
| Mar 31, 2021 | -9,000.00 |